Class Action Lawsuit Alert for Organon Shareholders
Kahn Swick & Foti, LLC (KSF), alongside former Louisiana Attorney General Charles C. Foti, Jr., has issued a critical notice to investors regarding a class action lawsuit against Organon & Co. (NYSE: OGN). Shareholders who have incurred losses exceeding $100,000 are particularly urged to review their options as the deadline for filing as a lead plaintiff approaches on July 22, 2025.
Important Details about the Lawsuit
The class action centers on the time frame extending from October 31, 2024, to April 30, 2025, during which the company allegedly failed to disclose significant information concerning its financial health. This lawsuit is currently pending before the United States District Court for the District of New Jersey.
In a concerning turn of events, Organon revealed its quarterly financial results on March 10, 2025, which shocked investors with news of a drastic dividend cut. The company announced that it was reducing its dividend payout from $0.28 to $0.02. This contradicted previous assurances given by management that maintaining the quarterly dividend was a top priority, raising legitimate concerns about the credibility of their communications.
As a direct consequence of this announcement, Organon's stock plummeted over 27%, dropping from a closing price of $12.93 on April 30, 2025, down to $9.45 by May 1, 2025. This incident emphasizes the severity of the situation and why affected shareholders need to act quickly.
Steps for Affected Shareholders
Investors affected by these circumstances are encouraged to contact KSF for a free consultation regarding their legal rights. You can reach Managing Partner Lewis Kahn at 1-877-515-1850 or via email at
email protected] For more information about the case, you can visit [KSF's dedicated Organon case page.
If you aspire to lead this class action lawsuit, it’s imperative to submit your petition to the court by the July 22 deadline. Failure to do so may result in a loss of the opportunity to recover financial losses incurred due to this alleged malpractice by Organon.
About Kahn Swick & Foti, LLC
Kahn Swick & Foti, LLC is recognized as one of America’s leading boutique securities litigation law firms, with its partners, including former Louisiana Attorney General Charles C. Foti, Jr., having extensive experience in securities law. Over the past year, KSF has achieved significant recognition, being ranked among the top 10 law firms nationally based on total settlement value. The firm's commitment is to serve a diverse clientele, including both institutional and retail investors, in their pursuit of recovering losses caused by corporate fraud and misconduct.
KSF operates from multiple locations, including New York, Delaware, California, Louisiana, Chicago, New Jersey, and even has a representative office in Luxembourg. If you would like to learn more about their services or the Organon case, please visit
KSF's website.
Conclusion
As the legal landscape continues to shift, it is crucial for Organon investors to stay informed and act decisively. The upcoming deadline to file as a lead plaintiff is a pressing matter, and KSF’s team stands ready to assist those in need. Don't miss this opportunity to seek justice and possible restitution for your financial losses.
Contact Information
For direct inquiries, you may contact:
Kahn Swick & Foti, LLC
Lewis Kahn, Managing Partner
Email: [email protected]
Phone: 1-877-515-1850
Address: 1100 Poydras St., Suite 960, New Orleans, LA 70163
Stay connected with KSF through their social media channels on FaceBook, Instagram, YouTube, TikTok, and LinkedIn.
This oversight makes it a vital issue for shareholders to monitor closely as the deadline approaches.